Senseye, Inc.: Clinical Trials

3 trials sponsored by Senseye, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Senseye, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
Senseye Diagnostic Tool (DT), Clinician Administered PTSD Scale for DSM-5, Revised Version - PTSD - Post Traumatic Stress Disorder
Phase 3RecruitingSenseye, Inc.19002026-02-232026-04-29
Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD
CAPS-5-R, Senseye DT - PTSD, Generalized Anxiety Disorder
CompletedSenseye, Inc.3382023-03-012024-12-11
Senseye's OBCI Diagnostic Tool for PTSD
CAPS-5 Assessment, Senseye OBCI - PTSD
TerminatedSenseye, Inc.612022-04-252023-04-12

Conditions studied

Stress Disorders, Post-Traumatic (3)  ·  Depressive Disorder, Major (2)  ·  Anxiety Disorders (1)  ·  Combat Disorders (1)  ·  Depression (1)  ·  Generalized Anxiety Disorder (1)  ·  Wounds and Injuries (1)

Countries

United States (3)  ·  Australia (1)

Top investigators

Naser Ahmadi, MD (1)